Leinco Technologies

Recombinant Human Galectin-7

Product Code:
 
LEI-G705
Product Group:
 
Recombinant Proteins
Host Type:
 
Human
Regulatory Status:
 
RUO
Shipping:
 
Ambient
Storage:
 
This lyophilized protein is stable for six to twelve months when stored desiccated at -20°C to -70°C. After aseptic reconstitution this protein may be stored at 2°C to 8°C for one month or at -20°C to -70°C in a manual defrost freezer. Avoid Repeated Freeze Thaw Cycles. See Product Insert for exact lot specific storage instructions.
 

No additional charges, what you see is what you pay! *

CodeSizePrice
LEI-G705-50ug50 ug£648.00
Quantity:
Prices exclude any Taxes / VAT
Stay in control of your spending. These prices have no additional charges, not even shipping!
* Rare exceptions are clearly labelled (only 0.14% of items!).
Multibuy discounts available! Contact us to find what you can save.
This product comes from: US.
Typical lead time: 14-21 working days.
Contact us for more accurate information.
  • Further Information
  • References
  • Show All

Further Information

Format:
This recombinant protein was 0.2 um filtered and lyophilized from modified Dulbecco?s phosphate buffered saline (1X PBS)and Betamercaptoethanol with Trehalose. pH 7.2 ? 7.3 with no calcium, magnesium, or preservatives.
Formulation:
This recombinant protein was 0.2 um filtered and lyophilized from modified Dulbecco?s phosphate buffered saline (1X PBS)and Betamercaptoethanol with Trehalose. pH 7.2 ? 7.3 with no calcium, magnesium, or preservatives.
Long Description:
Galectins belong to a family of related beta-galactoside-binding lectins, also referred to as S-type or S-Lac lectins. Galectin-7 (Gal-7) is highly expressed in the epidermis and contributes to different events associated with the differentiation and development of pluristratified epithelia (1). Gal-7 is also associated with epithelial cell migration, which plays a crucial role in the re-epithelialization process of corneal or epidermal wounds. In addition, recent evidence indicates that Gal-7, designated as the product of the p53-induced gene 1 (PIG1), is a regulator of apoptosis through JNK activation and mitochondrial cytochrome c release (2). Defects in apoptosis constitute one of the major hallmarks of human cancers and Gal-7 can act as either a positive or a negative regulatory factor in tumor development, depending on the histological type of the tumor. Specifically, this protein has been shown to increase susceptibility of keratinocytes to UVB induced apoptosis, an essential process in the maintenance of epidermal homeostasis (3).
NCBI Gene:
3963
Purity:
>97% by SDS-PAGE and analyzed by silver stain.
Target:
Galectin-7

References

1. Saussez, S. et al. (2006) Cell. Mol. Life Sci. 63:686 2. Bernerd, F. et al. (1999) Proc. Nat. Acad. Sci. (USA) 96:11329 3. Kuwabara, I. et al. (2002) J. Biol. Chem. 277:3487